Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-FR Version v4-FR
Language French French
Date Updated 2021-03-31 2019-05-28
Drug Identification Number 02443864 02443864
Brand name AURO-OLMESARTAN AURO-OLMESARTAN
Common or Proper name Olmesartan Medoxil Olmesartan Medoxil
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30, 500 30, 100 & 500
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-05-28 2019-05-28
Estimated end date 2021-03-31 2019-07-05
Actual end date 2020-07-16
Shortage status Resolved Anticipated shortage
Company comments Replaceable with Auro-Olmesartan 20mg Tab 100 Btl Limited stock of 100 packs
Health Canada comments